Bill > SJ50

This joint resolution requests the Legislative Council to designate an interim committee or direct staff resources to conduct a comprehensive study of the medical response to COVID-19, focusing on the short-term and long-term effects of COVID-19 vaccines, specific treatments like remdesivir and dexamethasone, and other drugs used during the pandemic. The study aims to examine the potential benefits of ivermectin as a COVID-19 treatment and explore the outcomes of Montana's Right to Try Act, which allows patients to access experimental treatments for active COVID-19 infections, long-term COVID-related health issues, and potential mitigation of vaccine side effects. The resolution requires that any findings be presented to and reviewed by an appropriate legislative committee, with all study aspects to be completed by September 15, 2026, and a final report to be submitted to the 70th Legislature. The preamble suggests that the federal government's approach to COVID-19 treatments may have compromised patient health and medical freedom through potentially inaccurate diagnoses and limited treatment options.